Organon & Co. Basic Shares Outstanding (Weighted Average)
Organon & Co. (OGN) reported Basic Shares Outstanding (Weighted Average) of 262.61 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-07-31
- Organon & Co. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 262.61M shares, a 1.03% increase year-over-year.
- Organon & Co. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 260.37M shares, a 0.97% increase year-over-year.
- Organon & Co. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 260.18M shares, a 0.97% increase year-over-year.
- Organon & Co. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 259.98M shares, a 0.96% increase year-over-year.
- Organon & Co. weighted average number of shares outstanding, basic for fiscal 2025 was 259.50M shares, a 0.95% increase from fiscal 2024.
- Organon & Co. weighted average number of shares outstanding, basic for fiscal 2024 was 257.05M shares, a 0.71% increase from fiscal 2023.
- Organon & Co. weighted average number of shares outstanding, basic for fiscal 2023 was 255.24M shares, a 0.46% increase from fiscal 2022.
- Organon & Co. weighted average number of shares outstanding, basic for fiscal 2022 was 254.08M shares, a 0.21% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 262.61M shares 10-Q · filed 2026-07-31 | 261.50M shares 10-Q · filed 2026-07-31 | 261.05M shares derived: average of 3 quarters · filed 2026-07-31 | 260.78M shares derived: average of 4 quarters · filed 2026-07-31 | ||
| 2026-03-31 | 260.37M shares 10-Q · filed 2026-05-04 | 260.28M shares derived: average of 2 quarters · filed 2026-05-04 | 260.18M shares derived: average of 3 quarters · filed 2026-05-04 | 260.12M shares derived: average of 4 quarters · filed 2026-07-31 | ||
| 2025-12-31 | 260.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 260.08M shares derived: average of 2 quarters · filed 2026-02-24 | 260.03M shares derived: average of 3 quarters · filed 2026-07-31 | 259.50M shares 10-K · filed 2026-02-24 | ||
| 2025-09-30 | 259.98M shares 10-Q · filed 2025-11-10 | 259.96M shares derived: average of 2 quarters · filed 2026-07-31 | 259.27M shares 10-Q · filed 2025-11-10 | 258.87M shares derived: average of 4 quarters · filed 2026-07-31 | ||
| 2025-06-30 | 259.94M shares 10-Q · filed 2026-07-31 | 258.91M shares 10-Q · filed 2026-07-31 | 258.50M shares derived: average of 3 quarters · filed 2026-07-31 | 258.25M shares derived: average of 4 quarters · filed 2026-07-31 | ||
| 2025-03-31 | 257.86M shares 10-Q · filed 2026-05-04 | 257.78M shares derived: average of 2 quarters · filed 2026-05-04 | 257.68M shares derived: average of 3 quarters · filed 2026-05-04 | 257.59M shares derived: average of 4 quarters · filed 2026-05-04 | ||
| 2024-12-31 | 257.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 257.60M shares derived: average of 2 quarters · filed 2026-02-24 | 257.49M shares derived: average of 3 quarters · filed 2026-02-24 | 257.05M shares 10-K · filed 2026-02-24 | ||
| 2024-09-30 | 257.50M shares 10-Q · filed 2025-11-10 | 257.39M shares derived: average of 2 quarters · filed 2025-11-10 | 256.83M shares 10-Q · filed 2025-11-10 | 256.53M shares derived: average of 4 quarters · filed 2026-02-24 | ||
| 2024-06-30 | 257.29M shares 10-Q · filed 2025-08-06 | 256.49M shares 10-Q · filed 2025-08-06 | 256.20M shares derived: average of 3 quarters · filed 2026-02-24 | 256.05M shares derived: average of 4 quarters · filed 2026-02-24 | ||
| 2024-03-31 | 255.69M shares 10-Q · filed 2025-05-02 | 255.66M shares derived: average of 2 quarters · filed 2026-02-24 | 255.63M shares derived: average of 3 quarters · filed 2026-02-24 | 255.56M shares derived: average of 4 quarters · filed 2026-02-24 | ||
| 2023-12-31 | 255.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 255.60M shares derived: average of 2 quarters · filed 2026-02-24 | 255.52M shares derived: average of 3 quarters · filed 2026-02-24 | 255.24M shares 10-K · filed 2026-02-24 | ||
| 2023-09-30 | 255.59M shares 10-Q · filed 2024-11-01 | 255.46M shares derived: average of 2 quarters · filed 2024-11-01 | 255.11M shares 10-Q · filed 2024-11-01 | 254.92M shares derived: average of 4 quarters · filed 2025-11-10 | ||
| 2023-06-30 | 255.34M shares 10-Q · filed 2024-08-07 | 254.87M shares 10-Q · filed 2024-08-07 | 254.70M shares derived: average of 3 quarters · filed 2025-11-10 | 254.61M shares derived: average of 4 quarters · filed 2025-11-10 | ||
| 2023-03-31 | 254.39M shares 10-Q · filed 2024-05-03 | 254.38M shares derived: average of 2 quarters · filed 2025-11-10 | 254.37M shares derived: average of 3 quarters · filed 2025-11-10 | 254.28M shares derived: average of 4 quarters · filed 2025-11-10 | ||
| 2022-12-31 | 254.37M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-11-10 | 254.36M shares derived: average of 2 quarters · filed 2025-11-10 | 254.25M shares derived: average of 3 quarters · filed 2025-11-10 | 254.08M shares 10-K/A · filed 2025-11-10 | ||
| 2022-09-30 | 254.35M shares 10-Q · filed 2023-11-03 | 254.18M shares derived: average of 2 quarters · filed 2023-11-03 | 253.99M shares 10-Q · filed 2023-11-03 | 253.88M shares derived: average of 4 quarters · filed 2024-02-26 | ||
| 2022-06-30 | 254.02M shares 10-Q · filed 2023-08-09 | 253.80M shares 10-Q · filed 2023-08-09 | 253.72M shares derived: average of 3 quarters · filed 2024-02-26 | 253.67M shares derived: average of 4 quarters · filed 2024-02-26 | ||
| 2022-03-31 | 253.58M shares 10-Q · filed 2023-05-05 | 253.57M shares derived: average of 2 quarters · filed 2024-02-26 | 253.56M shares derived: average of 3 quarters · filed 2024-02-26 | 253.55M shares derived: average of 4 quarters · filed 2024-02-26 | ||
| 2021-12-31 | 253.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | 253.55M shares derived: average of 2 quarters · filed 2024-02-26 | 253.54M shares derived: average of 3 quarters · filed 2024-02-26 | 253.54M shares 10-K · filed 2024-02-26 | 253.54M shares 10-K · filed 2022-03-21 | |
| 2021-09-30 | 253.53M shares 10-Q · filed 2022-11-04 | 253.53M shares derived: average of 2 quarters · filed 2022-11-04 | 253.53M shares 10-Q · filed 2022-11-04 | 253.52M shares derived: average of 4 quarters · filed 2023-02-27 | ||
| 2021-06-30 | 253.52M shares 10-Q · filed 2022-08-05 | 253.52M shares 10-Q · filed 2022-08-05 | 253.52M shares derived: average of 3 quarters · filed 2023-02-27 | 253.52M shares derived: average of 4 quarters · filed 2023-02-27 | ||
| 2021-06-02 | 253.52M shares 10-K · filed 2024-02-26 | |||||
| 2021-03-31 | 253.52M shares 10-Q · filed 2022-05-06 | 253.52M shares derived: average of 2 quarters · filed 2023-02-27 | 253.52M shares derived: average of 3 quarters · filed 2023-02-27 | 253.52M shares derived: average of 4 quarters · filed 2023-02-27 | ||
| 2020-12-31 | 253.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | 253.52M shares derived: average of 2 quarters · filed 2023-02-27 | 253.52M shares derived: average of 3 quarters · filed 2023-02-27 | 253.52M shares 10-K · filed 2023-02-27 | ||
| 2020-09-30 | 253.52M shares 10-Q · filed 2021-11-12 | 253.52M shares derived: average of 2 quarters · filed 2021-11-12 | 253.52M shares 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | 253.52M shares 10-Q · filed 2021-08-16 | 253.52M shares 10-Q · filed 2021-08-16 | ||||
| 2020-03-31 | 253.52M shares 10-Q · filed 2021-06-21 | |||||
| 2019-12-31 | 253.52M shares 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |